BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 18844296)

  • 1. Mass spectrometry in the characterization of human genetic N-glycosylation defects.
    Barone R; Sturiale L; Garozzo D
    Mass Spectrom Rev; 2009; 28(3):517-42. PubMed ID: 18844296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry for congenital disorders of glycosylation, CDG.
    Wada Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
    Faid V; Chirat F; Seta N; Foulquier F; Morelle W
    Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered glycan structures: the molecular basis of congenital disorders of glycosylation.
    Freeze HH; Aebi M
    Curr Opin Struct Biol; 2005 Oct; 15(5):490-8. PubMed ID: 16154350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis.
    Butler M; Quelhas D; Critchley AJ; Carchon H; Hebestreit HF; Hibbert RG; Vilarinho L; Teles E; Matthijs G; Schollen E; Argibay P; Harvey DJ; Dwek RA; Jaeken J; Rudd PM
    Glycobiology; 2003 Sep; 13(9):601-22. PubMed ID: 12773475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI-TOF MS.
    Sturiale L; Barone R; Palmigiano A; Ndosimao CN; Briones P; Adamowicz M; Jaeken J; Garozzo D
    Proteomics; 2008 Sep; 8(18):3822-32. PubMed ID: 18712764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congenital disorders of glycosylation].
    Durand G; Dupré T; Vuillaumier-Barrot S; Seta N
    Ann Pharm Fr; 2003; 61(5):330-9. PubMed ID: 13130291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
    Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
    Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular diagnosis of congenital disorders of glycosylation].
    Vuillaumier-Barrot S
    Ann Biol Clin (Paris); 2005; 63(2):135-43. PubMed ID: 15771971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and diagnosis of congenital disorders of glycosylation.
    Marklová E; Albahri Z
    Clin Chim Acta; 2007 Oct; 385(1-2):6-20. PubMed ID: 17716641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
    Wopereis S; Morava E; Grünewald S; Adamowicz M; Huijben KM; Lefeber DJ; Wevers RA
    Glycobiology; 2005 Dec; 15(12):1312-9. PubMed ID: 16037491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The underglycosylation of plasma alpha 1-antitrypsin in congenital disorders of glycosylation type I is not random.
    Mills K; Mills PB; Clayton PT; Mian N; Johnson AW; Winchester BG
    Glycobiology; 2003 Feb; 13(2):73-85. PubMed ID: 12626422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I.
    Callewaert N; Schollen E; Vanhecke A; Jaeken J; Matthijs G; Contreras R
    Glycobiology; 2003 May; 13(5):367-75. PubMed ID: 12626389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of protein glycosylation by mass spectrometry.
    Morelle W; Michalski JC
    Nat Protoc; 2007; 2(7):1585-602. PubMed ID: 17585300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms.
    Babovic-Vuksanovic D; O'Brien JF
    Mol Diagn Ther; 2007; 11(5):303-11. PubMed ID: 17963418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein glycosylation analyzed by normal-phase nano-liquid chromatography--mass spectrometry of glycopeptides.
    Wuhrer M; Koeleman CA; Hokke CH; Deelder AM
    Anal Chem; 2005 Feb; 77(3):886-94. PubMed ID: 15679358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.
    Sturiale L; Barone R; Fiumara A; Perez M; Zaffanello M; Sorge G; Pavone L; Tortorelli S; O'Brien JF; Jaeken J; Garozzo D
    Glycobiology; 2005 Dec; 15(12):1268-76. PubMed ID: 16037488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry of N-linked glycans.
    Azadi P; Heiss C
    Methods Mol Biol; 2009; 534():37-51. PubMed ID: 19277537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation.
    Cylwik B; Naklicki M; Chrostek L; Gruszewska E
    Acta Biochim Pol; 2013; 60(2):151-61. PubMed ID: 23730680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation.
    Foulquier F; Ungar D; Reynders E; Zeevaert R; Mills P; García-Silva MT; Briones P; Winchester B; Morelle W; Krieger M; Annaert W; Matthijs G
    Hum Mol Genet; 2007 Apr; 16(7):717-30. PubMed ID: 17220172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.